Lilly's New Obesity Drug Helps Patients Lose 30% Body Weight

Eli Lilly is preparing to seek FDA approval for retatrutide, a groundbreaking obesity drug that helped people lose up to 30% of their body weight in clinical trials.

The medicine could offer hope to millions struggling with obesity when it reaches the market in 2027.